Pascal soriot salary: AstraZeneca’s decision to move forward in developing COVID-19 vaccines and medicines has earned UK pharmaceutical global awards—and CEO Pascal Soriot a huge thank you.
In a “particularly difficult situation” and for its “inspiring leadership” in the response of COVID-19, AstraZeneca is giving Soriot £15.45 million ($21.52 million), to achieve the financial and scientific objectives, AZ’s Annual Report states (PDF).
That’s £140,000 more than his domestic wages in 2019, which were adjusted for current share prices. And £4.05 million was generated by stock gains which boost the long-term equity pay.
The sum includes the wages and bonuses of Soriot for 2020, plus the 2018 Equity Reward payments that relied on the success of AZ in the following years. The sum is regarded as “realised wage” [11.47 billion pounds], relative to cash and new equity grants, which Soriot received in 2020.
Of the overall compensation Soriot paid, 1,29 million pounds were paid out of base wages that were unchanged relative to 2019. His annual bonus soared to £2,32 million, which is twice his basic salary, or 90 percent of his full allowable. Half this bonus will not be automatically paid out but will be converted over three years into AZ securities.